Home/Filings/4/0001387131-19-001535
4//SEC Filing

MORRIS JESSICA EDGAR 4

Accession 0001387131-19-001535

CIK 0001430306other

Filed

Feb 26, 7:00 PM ET

Accepted

Feb 27, 5:37 PM ET

Size

7.8 KB

Accession

0001387131-19-001535

Insider Transaction Report

Form 4
Period: 2019-02-26
MORRIS JESSICA EDGAR
Chief Operating Officer
Transactions
  • Award

    Common Stock

    2019-02-26+5,1705,170 total
    Exercise: $1.89From: 2020-02-26Exp: 2029-02-25Common Stock (5,170 underlying)
  • Award

    Common Stock

    2019-02-26+5,1705,170 total
    Exercise: $2.36From: 2020-02-26Exp: 2029-02-25Common Stock (5,170 underlying)
Footnotes (2)
  • [F1]The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
  • [F2]The option was granted pursuant to the Issuer's 2018 Stock Incentive Plan.

Issuer

Tonix Pharmaceuticals Holding Corp.

CIK 0001430306

Entity typeother

Related Parties

1
  • filerCIK 0001656531

Filing Metadata

Form type
4
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 5:37 PM ET
Size
7.8 KB